Independent intelligence on healthtech across Asia and the Middle East
The delegation, spanning San Francisco, San Diego and Los Angeles, brought together more than 40 senior representatives from 16 Abu Dhabi government, healthcare, research and industry organisations.
With prostate cancer among the most commonly diagnosed cancers in men, the companies frame the deployment against rising diagnostic demand and pathology workforce pressures.
A study issued by M42 in partnership with the Department of Health – Abu Dhabi demonstrates how genomics enables prevention of vision loss and advances early detection of inherited eye…
The partnership plans to explore the development of next-generation AI tools to enhance care efficiency, advance precision medicine, and enable early preventive health interventions for employees.
The system enhances surgical accuracy but also facilitates quicker recovery, improved mobility, and long-term joint stability.
M42 formalised its 12-year presence in Saudi Arabia at the Global Health Exhibition in Riyadh, reinforcing alignment with Vision 2030 and commitment to preventive, data-driven healthcare.
Malaffi now represents 12.7 million unique patient profiles across Abu Dhabi to help progress the UAE’s advance in precision and preventive care.
A new study assessed AI Radiology in Screening TB (AIRIS-TB), M42's cutting-edge AI model engineered to streamline routine tuberculosis screenings, allowing radiologists to focus on more complex or urgent cases.
A new collaboration will combine genomics capabilities with AI to develop innovative therapeutics that target the underlying causes of age-related disease.